Literature DB >> 19815046

Matrix metalloproteinase-3 contributes to vulnerability of the nigral dopaminergic neurons.

Sung Tae Kim1, Eun-Mee Kim, Ji Hyun Choi, Hyo Jin Son, In Jung Ji, Tong H Joh, Sun Ju Chung, Onyou Hwang.   

Abstract

Dopamine(DA)rgic neurons are particularly vulnerable due to the presence of oxidative stress-inducing molecules such as DA, tetrahydrobiopterin, iron and tyrosine hydroxylase (TH). We have recently observed that matrix metalloproteinase-3 (MMP-3) is involved in degeneration of DArgic neurons. In the present study, we sought to explore the role of MMP-3 in DArgic neurons not exposed to apparent stress conditions. In 8-week-old male mice deficient of MMP-3 gene (MMP-3 KO), the total number of DArgic neurons in the substantia nigra was considerably higher than wild type (WT). Primary cultured mesencephalic neurons from MMP-3 KO showed higher [(3)H]DA uptake capability compared to that of WT. The number of TH-immunopositive neurons and the length of average dendritic branch were also greater. This appeared to be selective for the DArgic system, because [(3)H]GABA uptake and calbindin D-28K and MAP-2 immunoreactivities were unaltered. On the other hand, no differences were noted in the levels of the striatal DA, DOPAC and BH4 and TH protein between the KO and WT. Interestingly, TH immunodensity per cell was lower in the DArgic neurons of MMP-3 KO both in primary culture and in vivo, suggesting the presence of a compensatory mechanism. These results further indicate a role of MMP-3 in the demise of DArgic neurons and suggest MMP-3 as a candidate cellular target for neuroprotective therapy. 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19815046     DOI: 10.1016/j.neuint.2009.09.014

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  7 in total

1.  AETIQ: a novel synthetic compound with anti-inflammatory properties in activated microglia.

Authors:  Hyo Jin Son; Nari Shin; Eun Jung Shin; Dae Yoon Chi; Jai Woong Seo; Cheol Soon Lee; Onyou Hwang
Journal:  Inflammation       Date:  2014-06       Impact factor: 4.092

Review 2.  Matrix metalloproteinases in the brain and blood-brain barrier: Versatile breakers and makers.

Authors:  Ralf G Rempe; Anika M S Hartz; Björn Bauer
Journal:  J Cereb Blood Flow Metab       Date:  2016-06-20       Impact factor: 6.200

3.  MMP-3 contributes to nigrostriatal dopaminergic neuronal loss, BBB damage, and neuroinflammation in an MPTP mouse model of Parkinson's disease.

Authors:  Young Cheul Chung; Yoon-Seong Kim; Eugene Bok; Tae Young Yune; Sungho Maeng; Byung Kwan Jin
Journal:  Mediators Inflamm       Date:  2013-06-19       Impact factor: 4.711

4.  Matrix metalloproteinase-3 causes dopaminergic neuronal death through Nox1-regenerated oxidative stress.

Authors:  Dong-Hee Choi; Ji-Hye Kim; Joo-Ha Seo; Jongmin Lee; Wahn Soo Choi; Yoon-Seong Kim
Journal:  PLoS One       Date:  2014-12-23       Impact factor: 3.240

5.  Potential Tear Biomarkers for the Diagnosis of Parkinson's Disease-A Pilot Study.

Authors:  Arantxa Acera; Juan Carlos Gómez-Esteban; Ane Murueta-Goyena; Marta Galdos; Mikel Azkargorta; Felix Elortza; Noelia Ruzafa; Oliver Ibarrondo; Xandra Pereiro; Elena Vecino
Journal:  Proteomes       Date:  2022-01-13

6.  Correlation of matrix metalloproteinase 3 and matrix metalloproteinase 9 levels with non-motor symptoms in patients with Parkinson's disease.

Authors:  Chuan Ze Liu; Da Shuai Guo; Jian Jun Ma; Lin Rui Dong; Qing Qing Chang; Hong Qi Yang; Ke Ke Liang; Xiao Huan Li; Da Wei Yang; Yong Yan Fan; Qi Gu; Si Yuan Chen; Dong Sheng Li
Journal:  Front Aging Neurosci       Date:  2022-08-22       Impact factor: 5.702

7.  Promising Molecular Targets for Pharmacological Therapy of Neurodegenerative Pathologies.

Authors:  M E Neganova; Yu R Aleksandrova; V O Nebogatikov; S G Klochkov; A A Ustyugov
Journal:  Acta Naturae       Date:  2020 Jul-Sep       Impact factor: 1.845

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.